01 September, 2017
We have $17.07 PT which if reached, will make NYSE:TEVA worth $991.20 million more. Sumitomo Mitsui Trust Holdings, Inc. grew its position by buying 23,246 shares an increase of 0.9% from 03/31/2017 to 06/30/2017. BidaskClub cut shares of Teva Pharmaceutical Industries Limited from a "sell" rating to a "strong sell" rating in a research report on Wednesday, August 16th. The firm experienced a fall in short interest from July 31, 2017 to August 15, 2017 of -8.67%. It has outperformed by 11.80% the S&P500. Innerworkings had 4 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has "Equal Weight" rating given on Tuesday, January 31 by Barclays Capital. A company with a high dividend yield pays its investors a large dividend compared to the fair market value of the stock. The firm's market capitalization is $15.71 billion. The Company's software applications and databases create an integrated solution that stores, analyzes and tracks the production capabilities of its supplier network, as well as detailed pricing data.
Moving focus toward profitability ratios, the return on equity was booked as -21.20%, while return on assets was -6.70%. The Company's divisions include North America and worldwide.
Investors sentiment increased to 0.93 in Q4 2016.
Since March 1, 2017, it had 0 insider purchases, and 7 sales for $16.39 million activity. The company reported $0.99 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.06 by $0.07. 58 funds opened positions while 108 raised stakes. Parallax Volatility Advisers Ltd Partnership holds 26,085 shares or 0% of its portfolio. Parametric Portfolio Ltd Com owns 458,767 shares or 0.01% of their United States portfolio. Oak Associates Ltd. OH now owns 379,924 shares of the company's stock valued at $12,621,000 after buying an additional 2,114 shares during the period. Kings Point Cap Mngmt owns 458 shares. Mcclain Value Mgmt Limited Co invested in 583,049 shares. Analyst IMS Investment Management Services Ltd. now owns 9,051 shares of the company's stock valued at $300,000 after buying an additional 700 shares during the period. (NASDAQ:INWK). Goldman Sachs Group Inc holds 94,398 shares. The dividend will be $0.275 per share for the quarter which is $1.10 annualized. Finally, Mitsubishi UFJ Kokusai Asset Management Co. (NASDAQ:GILD) or 45,523 shares. 10,070 are owned by Bancorp Of Montreal Can.
China Automotive Systems, Inc., is a holding company. Genesis also owns interests in a Brazil trading company, which engages mainly in the import and sales of automotive parts in Brazil. Landscape Capital Management Lc has invested 0.02% in Tilly's Inc (NYSE:TLYS). Therefore 22% are positive. From the opening price, the stock has seen a change of 2.80% recently clocking in with a price of $16.14. Vetr raised Teva Pharmaceutical Industries Limited from a hold rating to a buy rating and set a $34.17 target price for the company in a research report on Monday, July 24th. Looking out over the past year, company shares have been recorded -69.35% off the 52 week high and 5.35% away from the low over the same period.Covering sell-side analysts have recently weighed in on shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA).
On August 24 the company was set at "Underperform" in a report from Credit Suisse which is down from the previous "Market Perform" rating. The rating was maintained by Piper Jaffray on Thursday, August 3 with "Hold". Bank of America downgraded the stock to "Neutral" rating in Monday, November 7 report.
More notable recent Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news were published by: Investorplace.com which released: "Why Transocean LTD (RIG), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and ..." on August 16, 2017, also Schaeffersresearch.com with their article: "Telsey Turns on Chipotle; Teva Pharmaceutical Stock Tries to Bounce" published on August 30, 2017, Investorplace.com published: "Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?" on August 02, 2017.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
